A paradigm shift in melanoma treatment
Drug therapy looks set to become the standard treatment for high-risk early stage melanoma patients.
Drug therapy looks set to become the standard treatment for high-risk early stage melanoma patients.
“The future looks bright – I truly believe that we will get to zero deaths from melanoma with the trajectory we’re following.”
The Garrow family honour their dearly loved family member Ben with the Ben Garrow PhD Scholarship.
The Retreat shared highlights from MIA-led research activities. Despite COVID research has continued unabated.
Successful trial of a new immunotherapy drug which offers a third, and less toxic, option for the treatment of advanced melanoma.
As leaders in melanoma field, researchers from MIA shared their knowledge at 10th World Congress of Melanoma.
New research has shed light on why advanced melanoma that has spread to the liver is particularly resistant to immunotherapy.
The discovery of dramatic genetic changes may be key to developing new melanoma treatments.
MIA Co-Medical Director, Professor Georgina Long, who has been recognised in the 2020 Queen’s Birthday Honours List.
MIA's world leading researchers receive NHMRC grants to further their melanoma research, taking us closer to reaching zero deaths from melanoma.